Exosomes miR-369-3p Alleviates Early Brain Injury After Subarachnoid Hemorrhage by Promoting Ferroptosis of M1

Jian Fang1, Feiyun Qin1, Pengcheng Xu2

  • 1Department of Neurosurgery, The Translational Research Institute for Neurological Disorders of Wannan Medical College, The First Affiliated Hospital of Wannan Medical College (Yijishan Hospital of Wannan Medical College), Wuhu, Anhui, China.

Brain and Behavior
|October 12, 2025
PubMed
Abstract

Insights

This study shows that engineered exosomes carrying miR-369-3p can cross the blood-brain barrier to treat early brain injury after subarachnoid hemorrhage. The treatment reduces M1 microglia-mediated inflammation and neuronal damage by promoting ferroptosis.

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Molecular Biology

Background:

  • Ferroptosis plays a role in early brain injury following subarachnoid hemorrhage (SAH-EBI).
  • MicroRNAs (miRNAs) are implicated in neurological disorders, with exosomal miR-369-3p potentially regulating inflammation in SAH.
  • Targeted delivery of miR-369-3p across the blood-brain barrier (BBB) offers a promising therapeutic strategy for SAH-EBI.

Purpose of the Study:

  • To investigate the therapeutic potential of exosome-mediated delivery of miR-369-3p for SAH-EBI.
  • To explore the mechanism by which miR-369-3p affects M1 microglia and ferroptosis in the context of SAH.

Main Methods:

  • Exosomes were modified with RVG peptide and loaded with miR-369-3p mimic (RVG-Exo/miR).
  • RVG-Exo/miR was administered via tail vein injection to SAH mice to facilitate BBB crossing.
  • Neurobehavioral outcomes, brain water content, neuronal damage, and ferroptosis markers were assessed.

Main Results:

  • RVG-Exo/miR successfully delivered miR-369-3p into the mouse central nervous system.
  • Treatment reduced M1 microglia by promoting ferroptosis via inhibition of iNOS and GPX4.
  • miR-369-3p administration alleviated neurobehavioral deficits, brain edema, and neuronal injury.

Conclusions:

  • RVG-Exo/miR promotes M1 microglia ferroptosis by inhibiting the iNOS/GPX4 axis.
  • This approach represents a novel and effective therapeutic strategy for SAH-EBI.